BDNF and Huntington disease: This property was shown to strengthen in a polyglutamine repeat-dependent manner, which altered the binding of MeCP2 to promoter IV of Bdnf, and resulted in its downregulation in the STHdh111/111 cell model of HD (Figure 1B).